Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Sanofi
SNY · SEC Filings
website
76.5K
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, developmen...
Price
48.12
Market Cap
115.87 B
Float
2.16 B
Country
FR
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about SNY
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Sanofi
SNY · SEC Filings
2.16 B
Float
48.12
Price
115.87 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
News
TYPE
HEADLINE
FILED AT
6-K
Sanofi Reports Q3 2026 Double-Digit Growth and Upgrades Full-Year Guidance
Oct 30, 2026
6-K
Sanofi breaks ground on new insulin manufacturing facility in Germany
Oct 26, 2026
6-K
Sanofi and Regeneron Expand Global Alliance for Next-Generation Immunology Antibodies
Oct 1, 2026
6-K
Sanofi and Cheplapharm to Create Strategic Partnership in Mature Medicines
Sep 17, 2026
6-K
Sanofi’s MenQuadfi Approved in the EU for Infants Starting at Six Weeks of Age
Aug 6, 2026
6-K
Sanofi Half-Year Financial Report 2026
Jul 30, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
Oct 29, 2025
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]
Oct 27, 2025
424B5
$1,000,000,000 3.375% Notes due 2023
Jun 14, 2018
424B5
12,799
Jun 12, 2018
424B3
Registration
Mar 24, 2014
424B5
$1,500,000,000 1.250% Notes due 2018
Apr 5, 2013
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 17, 2026
SC TO-T/A
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Feb 10, 2026
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 5, 2026
SC TO-T/A
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Jan 30, 2026
SC TO-T/A
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Jan 28, 2026
SC TO-T
Form SC TO-T - Tender offer statement by Third Party
Jan 12, 2026
Proxies
TYPE
HEADLINE
FILED AT
N-PX
Form N-PX - Annual Report of proxy voting record of management investment companies
Aug 25, 2026
N-PX
Form N-PX - Annual Report of proxy voting record of management investment companies
Jul 30, 2025
DFAN14A
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
Jul 5, 2016
DFAN14A
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
Jun 14, 2016
DFAN14A
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
Jun 13, 2016
DEFC14A
Form DEFC14A - Definitive proxy statement, contested solicitations
Jun 13, 2016
Ownerships
TYPE
HEADLINE
FILED AT
13F-HR
Form 13F-HR - Quarterly report filed by institutional managers, Holdings
Nov 5, 2026
SCHEDULE 13G/A
Amundi (Filed by)
Oct 26, 2026
4
Sanofi (Reporting)
Aug 12, 2026
3
Sanofi (Reporting)
Aug 12, 2026
4
Sanofi (Reporting)
Aug 7, 2026
3
Sanofi (Reporting)
Aug 4, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
SD
Form SD - Specialized disclosure report
May 28, 2026
SD
Form SD - Specialized disclosure report
May 21, 2025
SD
Form SD - Specialized disclosure report
May 28, 2024
LETTER
Form UPLOAD - SEC-generated letter
Apr 24, 2024
CORRESP
Form CORRESP - Correspondence
Apr 24, 2024
LETTER
Form UPLOAD - SEC-generated letter
Apr 11, 2024
